Journal
IMMUNITY
Volume 52, Issue 3, Pages 542-+Publisher
CELL PRESS
DOI: 10.1016/j.immuni.2020.02.007
Keywords
-
Categories
Funding
- Japan Science and Technology Agency (JST) [15H05704, 16H06234, T17K195570, 18H05032]
- Visionary Research Fund from Takeda Science Foundation
- PRIME [17 gm6110002h0001]
- ACT-M [17im0210108h0001]
- Japan Agency for Medical Research and Development, AMED [18fk0310106h0002, 18fk0210041h0001]
- Grants-in-Aid for Scientific Research [16H06234, 15H05704, 18H05032] Funding Source: KAKEN
Ask authors/readers for more resources
Fibrosis is an incurable disorder of unknown etiology. Segregated-nucleus-containing atypical monocytes (SatMs) are critical for the development of fibrosis. Here we examined the mechanisms that recruit SatMs to pre-fibrotic areas. A screen based on cytokine expression in the fibrotic lung revealed that the chemokine Cxcl12, which is produced by apoptotic nonhematopoietic cells, was essential for SatM recruitment. Analyses of lung tissues at fibrosis onset showed increased expression of Rbm7, a component of the nuclear exosome targeting complex. Rbm7 deletion suppressed bleomycin-induced fibrosis and at a cellular level, suppressed apoptosis of nonhematopoietic cells. Mechanistically, Rbm7 bound to noncoding (nc)RNAs that form subnuclear bodies, including Neat1 speckles. Dysregulated expression of Rbm7 resulted in the nuclear degradation of Neat1 speckles, the dispersion of the DNA repair protein BRCA1, and the triggering of apoptosis. Thus, Rbm7 in epithelial cells plays a critical role in the development of fibrosis by regulating ncRNA decay and thereby the production of chemokines that recruit SatMs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available